#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14648	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2084	698.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1467	1467	C	892	C	832	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14648	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2084	698.3	0	HET	.	.	.	C207T	.	207	207	C	490	490	C	796	C,T	609,130	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14648	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2084	698.3	0	HET	.	.	.	C451T,A	.	451	451	C	734	734	C	854	C,T,A	625,169,2	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14648	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2084	698.3	0	HET	.	.	.	C1036T	.	1036	1036	C	1319	1319	C	876	C,T	586,229	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26686	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3572	744.2	0	.	n	.	0	T695C	SNP	695	695	T	1073	1073	C	820	C,T	766,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26686	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3572	744.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2349	2349	C	883	C	815	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26686	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3572	744.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2423	2423	A	861	A	811	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26686	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3572	744.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	2975	2975	C	843	C	797	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26686	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3572	744.2	0	HET	.	.	.	A1638G,T	.	1638	1638	A	2016	2016	A	848	A,G,T	601,198,1	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1576	folP	855	855	100.0	folP.l15.c17.ctg.1	1489	105.3	1	SNP	p	R229S	1	.	.	685	687	AGC	1001	1003	AGC	152;153;151	A;G;C	146;147;145	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4390	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3391	128.9	1	SNP	p	S91F	1	.	.	271	273	TTC	597	599	TTC	161;161;157	T;T;C	150;150;146	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4390	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3391	128.9	1	SNP	p	D95G	1	.	.	283	285	GGC	609	611	GGC	158;155;155	G;G;C	148;145;145	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4390	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3391	128.9	1	SNP	p	G95N	0	.	.	283	285	GGC	609	611	GGC	158;155;155	G;G;C	148;145;145	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	1402	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1261	110.5	1	SNP	p	G45D	0	.	.	133	135	GGC	462	464	GGC	179;179;177	G;G;C	167;169;165	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	716	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c30.ctg.1	1018	69.9	0	.	n	.	0	A197.	DEL	197	197	A	593	593	A	167	A	160	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5672	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2823	199.7	1	SNP	p	D86N	0	.	.	256	258	GAC	518	520	GAC	198;194;195	G;A;C	184;178;187	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5672	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2823	199.7	1	SNP	p	R87W	0	.	.	259	261	CGT	521	523	CGT	195;195;198	C;G;T	185;182;185	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5672	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2823	199.7	1	SNP	p	R87I	0	.	.	259	261	CGT	521	523	CGT	195;195;198	C;G;T	185;182;185	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5672	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2823	199.7	1	SNP	p	S87R	1	.	.	259	261	CGT	521	523	CGT	195;195;198	C;G;T	185;182;185	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5672	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2823	199.7	1	SNP	p	S88P	0	.	.	262	264	TCC	524	526	TCC	198;198;199	T;C;C	185;189;187	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3560	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2640	134.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1487	1489	GGC	163;165;164	G;G;C	153;155;150	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3418	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2521	135.2	1	SNP	p	A311V	0	.	.	931	933	GCC	1238	1240	GCC	196;196;198	G;C;C	185;186;187	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3418	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2521	135.2	1	SNP	p	I312M	1	.	.	934	936	ATG	1241	1243	ATG	200;203;202	A;T;G	190;193;190	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3418	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2521	135.2	1	SNP	p	T316P	0	.	.	946	948	ACC	1253	1255	ACC	201;205;203	A;C;C	192;197;197	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3418	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2521	135.2	1	SNP	p	V316T	1	.	.	946	948	ACC	1253	1255	ACC	201;205;203	A;C;C	192;197;197	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3418	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2521	135.2	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1754	1756	ACC	166;165;166	A;C,T;C	153;152,1;154	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3418	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2521	135.2	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1808	1810	GCG	170;171;168	G;C;G	163;165;162	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3418	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2521	135.2	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1808	1810	GCG	170;171;168	G;C;G	163;165;162	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3418	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2521	135.2	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1931	1933	GGT	143;141;140	G;G;T	133;132;131	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3418	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2521	135.2	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1940	1942	AGC	136;137;135	A;G;C	124;126;124	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3418	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2521	135.2	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1958	1960	CCG	118;120;121	C,G;C;G,A	92,5;93;96,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5530	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	3102	177.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1665	1667	CCG	199;196;195	C;C;G	183;184;173	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2234	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1636	135.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	491	491	C	165	C	149	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3086	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1544	198.1	1	SNP	p	G120K	1	.	.	358	360	AAG	591	593	AAG	269;270;268	A;A;G	253;254;247	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3086	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1544	198.1	1	SNP	p	N121D	0	.	.	361	363	AAC	594	596	AAC	270;272;269	A;A;C	251;255;252	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3086	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1544	198.1	1	SNP	p	A121N	1	.	.	361	363	AAC	594	596	AAC	270;272;269	A;A;C	251;255;252	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11604	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4764	242.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1242	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1005	122.6	1	SNP	p	V57M	1	.	.	169	171	ATG	553	555	ATG	243;245;245	A,G;T;G	231,1;234;234	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
